Status:
UNKNOWN
Determination of ALDH1b1 and ALDH2 Polymorphisms Frequency in the Brazilian Population
Lead Sponsor:
Instituto do Cancer do Estado de São Paulo
Collaborating Sponsors:
Instituto de Ciências Biomédicas da Universidade de São Paulo
Conditions:
Oral Squamous Cell Carcinoma (OSCC)
Eligibility:
All Genders
18+ years
Brief Summary
A case-control study with oral squamous cell carcinoma (OSCC) patients from Instituto do Câncer do Estado de São Paulo (ICESP) and healthy volunteers. In this study, it will be collected saliva sample...
Detailed Description
According to the World Health Organization (WHO), in 2016 there were 3 million deaths worldwide from alcohol abuse. ALDH1b1 and ALDH2 proteins are involved in the alcohol metabolism promoting the conv...
Eligibility Criteria
Inclusion
- OSCC diagnostic for case group
- Able to read and sign the consent form.
- Able for saliva collection.
- Able to understand the applied questionnaires.
Exclusion
- Unable to read and sign the consent form.
- Unable for saliva collection.
- Unable to understand the applied questionnaires.
- OSCC patient's companions for healthy volunteers.
Key Trial Info
Start Date :
January 2 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04270201
Start Date
January 2 2022
End Date
December 1 2023
Last Update
May 19 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Instituto do Câncer do Estado de São Paulo
São Paulo, São Paulo, Brazil, 01246-000